Trials / NCT05793515
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models
Completed Observational Natural history / observational
- Sponsor
- Istituto Superiore di Sanità
- Treatment
- whole genome sequencing
- Gene
- Not stated
- Conditions
- Inherited Retinal Dystrophy, Retinitis Pigmentosa, Macular Dystrophy
- Ages
- 5 Years to 80 Years
- Enrollment
- 120 participants
- Started
- 2022-11-15
- Main results expected
- 2024-11-02
- Results posted
- Not yet
- Record last updated
- 2025-04-18
What the study is testing
Inherited retinal dystrophies (IRDs), a large group of heterogeneous and rare disorders, may result in irreversible bilateral visual loss and blindness. Characterizing the genetic bases of IRDs will help to understand the pathogenesis underlying the development of retinal damage. Despite the advances in molecular identification of genes causing disease, unsolved IRDs constitute about 40% of all cases.
Goal of this study is to solve missing heritability in IRD using whole genome sequencing (WGS) to identify the genetic causes in clinically well-characterized patients without a molecular diagnosis.
The identification of novel genes that have a role in the development or maintenance of retinal function will lead to the development of new therapeutic approaches and will favour a more prompt diagnosis and improvement of patient management.
Where it runs
Italy (1)
- Istituto Superiore di Sanità-Dpt. Oncology and Molecular Medicine, Rome, Italy